Another multinational pharmaceutical company wants to split Novo Nordisk and release its 2019 financial report
-
Last Update: 2020-02-06
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
(2020 / 02 / 06) how to promote ADC drug research and development with a total financing of 558 million US dollars? Novo Nordisk 2019 financial report announced: China's revenue is 13.2 billion yuan; two pulmonary hypertension drugs are to be included in the priority review at the same time; Maat Pharma announced the completion of 18 million euro B round financing GSK estimates that the one-time cost of the spin off is about £ 600-700 million Novo Nordisk focuses on endocrine (diabetes, obesity, dwarfism) and hemophilia The two drugs are Pfizer's sildenafil citrate tablets and Puji bio's maxitan tablets ADC drugs are emerging The frequency of 40 Hz is due to the lack of gamma waves in the early brain of Alzheimer's patients.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
